You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

PROSCAR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Proscar patents expire, and what generic alternatives are available?

Proscar is a drug marketed by Organon and is included in one NDA.

The generic ingredient in PROSCAR is finasteride. There are fourteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the finasteride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Proscar

A generic version of PROSCAR was approved as finasteride by DR REDDYS LABS INC on July 28th, 2006.

  Try a Trial

Drug patent expirations by year for PROSCAR
Drug Prices for PROSCAR

See drug prices for PROSCAR

Recent Clinical Trials for PROSCAR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Baylor College of MedicinePhase 3
Medical Research Collaborating Center, Seoul, KoreaPhase 4
Astellas Pharma Korea, Inc.Phase 4

See all PROSCAR clinical trials

Pharmacology for PROSCAR

US Patents and Regulatory Information for PROSCAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PROSCAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ⤷  Try a Trial ⤷  Try a Trial
Organon PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ⤷  Try a Trial ⤷  Try a Trial
Organon PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for PROSCAR

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0155096 93C0055 Belgium ⤷  Try a Trial PRODUCT NAME: FINASTERIDUM; NAT. REG..: 922 IS 151 F 3 19930125; FIRST REG.: GB PL 0025/0279 19920527
0155096 SPC/GB93/006 United Kingdom ⤷  Try a Trial SPC/GB93/006:, EXPIRES: 20070526
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.